Literature DB >> 10511341

Positron emission tomography using [18F] fluorodeoxyglucose and [11C] l-methionine to metabolically characterize dysembryoplastic neuroepithelial tumors.

A M Kaplan1, M A Lawson, J Spataro, D J Bandy, C T Bonstelle, S D Moss, K H Manwaring, E M Reiman.   

Abstract

Dysembryoplastic neuroepithelial tumors are unique and benign congenital tumors occurring frequently in children and adolescents. Differentiation from other low-grade tumors is important for management. Five patients with confirmed dysembryoplastic neuroepithelial tumors were studied with positron emission tomography using glucose and protein metabolic uptake in an attempt to categorize these tumors metabolically. Functional brain mapping also was obtained to aid in operative management. Results of the study conclude that dysembryoplastic neuroepithelial tumors, although having similar neuroimgaing characteristics to other low-grade tumors, are distinguished by a unique metabolic profile. They are inactive tumors with no significant glucose or protein metabolic activity. The combination of preoperative positron emission tomographic metabolic studies with functional brain mapping allowed for prediction of tumor type, defined eloquent areas of cortical function, and improved approach and resection of the tumors with minimal risk of neurologic impairment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10511341     DOI: 10.1177/088307389901401009

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  9 in total

1.  Has PET become an important clinical tool in paediatric imaging?

Authors:  Klaus Hahn; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-05       Impact factor: 9.236

2.  [11C]-Methionine PET: dysembryoplastic neuroepithelial tumours compared with other epileptogenic brain neoplasms.

Authors:  D S Rosenberg; G Demarquay; A Jouvet; D Le Bars; N Streichenberger; M Sindou; N Kopp; F Mauguière; P Ryvlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

Review 3.  2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.

Authors:  John Freebody; Eva A Wegner; Monica A Rossleigh
Journal:  World J Radiol       Date:  2014-10-28

4.  Cortical dysplasia localized by [11C]methionine positron emission tomography: case report.

Authors:  Padma Vasantha Madakasira; Robert Simkins; Tanjore Narayanan; Kelly Dunigan; Raymond J Poelstra; Joseph Mantil
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

5.  Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors.

Authors:  Bálint Alkonyi; Sandeep Mittal; Ian Zitron; Diane C Chugani; William J Kupsky; Otto Muzik; Harry T Chugani; Sandeep Sood; Csaba Juhász
Journal:  J Neurooncol       Date:  2011-11-03       Impact factor: 4.130

Review 6.  PET and SPECT studies in children with hemispheric low-grade gliomas.

Authors:  Csaba Juhász; Edit Bosnyák
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

7.  Accuracy of distinguishing between dysembryoplastic neuroepithelial tumors and other epileptogenic brain neoplasms with [¹¹C]methionine PET.

Authors:  Sylvain Rheims; Sebastià Rubi; Sandrine Bouvard; Emilien Bernard; Nathalie Streichenberger; Marc Guenot; Didier Le Bars; Alexander Hammers; Philippe Ryvlin
Journal:  Neuro Oncol       Date:  2014-03-05       Impact factor: 12.300

8.  The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood.

Authors:  Michael C Kruer; Allen M Kaplan; Michael M Etzl; David F Carpentieri; Paul S Dickman; Kewei Chen; Kathleen Mathieson; Alison Irving
Journal:  J Neurooncol       Date:  2009-06-09       Impact factor: 4.130

9.  PET imaging in the surgical management of pediatric brain tumors.

Authors:  Benoit Pirotte; Francesco Acerbi; Alphonse Lubansu; Serge Goldman; Jacques Brotchi; Marc Levivier
Journal:  Childs Nerv Syst       Date:  2007-03-14       Impact factor: 1.532

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.